Pop, six, squish: do both popsicle advertisers have it coming?

Here, false advertising claims generate false advertising counterclaims, serving as a reminder that the advertiser who goes to court needs to have its own house in order.

Austin’s Natural Frozen Pops, Inc. v. Jonny Pops, LLC, 2025
WL 3182084, No. 1:24-CV-716-RP (W.D. Tex. Mar. 13, 2025)

The parties target consumers seeking “better-for-you” treat
options, selling in healthy grocery stores like Whole Foods and Sprouts. JonnyPops’
boxes show pictures of fruit, and JonnyPops advertises that its products are
made from “simple ingredients,” are made with ingredients like “100% real
fruit,” and have the “wholesome nutrition of a fruit bar.” JonnyPops also
displays the “USDA Organic” label prominently on its packaging.

JonnyPops boxes

GoodPop alleged that this violated California law and the
Lanham Act because the two main ingredients in JonnyPops’s pops are water and
added cane sugar, and any fruit in the products is only miniscule amounts. And,despite
displaying lemons, limes, blue raspberries, and grapes on the packaging for
JonnyPops’s “Fruit Stacks” treats, the product allegedly contains none of those
fruits. GoodPop’s survey of household grocery shoppers aged 18 to 65 years
allegedly found that 50% of respondents believed JonnyPops’s “Fruit Stacks”
treat was made primarily out of fruit, while the treat allegedly contains less
than 2% fruit content. Likewise, JonnyPops’s advertising allegedly led 61% of
respondents to believe that the majority of the sugar in the product came from
fruit. GoodPop’s complaint also cited customer reviews that praise JonnyPops’s
pops for being a healthier option and having relatively low sugar, and alleged
deception among retailers as well.

GoodPop alleged that JonnyPops models its mission, brand
positioning, and pops after GoodPop’s. While GoodPop uses Good in its name to
refer not only to the ingredients in its products, “but also its desire to
inspire a ‘World of Good,’” JonnyPops advertises its mission to be “Make the
World A Better Place, One Pop At A Time.” JonnyPops allegedly uses “nearly
identical flavors” and similar package design and claims. [In the absence of a
trade dress claim—and flavors are surely functional for ice pops—how could that
matter?]

JonnyPops boxes with same flavors as Goodpop boxes

First, JonnyPops argued that the images of fruit do not
mislead consumers when viewed in context of the entire package, because the
fruit images indicate flavors, rather than ingredients, especially in
combination with the ingredients list on the side or back of the package. But
“the mere presence of an ingredient statement on the back of the product ‘does
not eliminate the possibility that reasonable consumers may be misled.’” Misleadingness
was plausible. Nor were the pictures and the “simple ingredient” claim
non-actionable puffery. The statements at issue here, especially the pictures, weren’t
exaggerated in the way typically associated with non-actionable puffery: words
like “best,” “better,” and “favorite.” Even if “simple” may be subjective, it
was the phrase “simple ingredients” in combination with the fruit pictures and
the rest of JonnyPops’s advertising that allegedly misled consumers; that
context made the claim plausibly misleading.

Deception was plausible based on the survey as well as
consumer reviews, along with allegations that “a nutritionist with more than 1
million followers on social media” recommended JonnyPops over another pop that
contained less sugar, mistakenly believing that it was JonnyPops’s pop that had
less sugar.

The consumer reviews also plausibly showed materiality.
E.g., consumers believed and cared about claims that the pops have “a lower
sugar content and appear[] to be a better for you[] product tha[n] your typical
pop” and are “made of all natural ingredients and had good nutrition compared
to a lot of sugar brands.”

And injury was plausible because of the direct competition,
and because of allegations that, “where retailers have limited space to stock
either GoodPop or JonnyPops in their better-for-you section, retailers have
chosen JonnyPops due to its deceptive sales presentations, because JonnyPops is
not truly a better-for-you product.” For example, “when JonnyPops began selling
next to GoodPop as a better-for-you product in one health grocer, GoodPops’s
sales velocity declined by about 25%.”

The state law claims survived for the same reason; it was ok
to assert California claims in Texas because the alleged wrongful conduct
occurred in California.

Austin’s Natural Frozen Pops, Inc. v. Jonny Pops, LLC, 2025
WL 3182084, No. 1:24-CV-716-RP (W.D. Tex. Nov. 10, 2025)

The parties compete in the market for “ice pops.” GoodPop sued
JonnyPops under the Lanham Act and also for violations of California’s unfair
competition law. JonnyPops counterclaimed under the same laws, alleging that
GoodPop has “duped consumers into thinking that its products are nutritionally
superior to other ice pops, including JonnyPops’s products.” The court refused
to dismiss some of the counterclaims.

GoodPop allegedly falsely claimed that “[i]f it’s a GoodPop,
it’ll never have … refined sugars,” even though many of its products “contain
cane sugar, which is always refined to some extent,” citing definitions of “raw
sugar,” “sugar,” and “cane sugar.” It alleged that four consumer reviews showed
consumer belief and reliance. The court found that, at this stage, it would
accept the claim that cane sugar is refined sugar. Thus, JonnyPops had alleged
actual falsity and didn’t have to provide separate evidence of
deception/materiality; in the alternative, three of the alleged online reviews “specifically
refer to GoodPop’s products not containing refined sugar, which make it
plausible that GoodPop’s alleged deception is material.”

refined sugar claim on box

Second, JonnyPops alleged that GoodPop’s website makes the
false or misleading statement, “The fruit in GoodPops is real and really good!
We use real, whole fruits, juices and purees” when (1) certain GoodPops do not
contain any fruit, and (2) some GoodPops that do contain fruit ingredients are
made with fruit-juice concentrates and other additives, rather than “whole
fruit, juices or purees.” It quoted seven online consumer reviews that mention
GoodPops containing 100% fruit juice.

Cherry n’ Lemonade flavor

First, it wasn’t plausible that consumers would be deceived
by SKUs whose names didn’t claim fruit: the Disney Mickey Mouse Fudge n’
Vanilla Pop, the Fudge n’ Vanilla Crunch Pop, the Fudge n’ Caramel Crunch Pop,
and the Chocolate Vanilla Sandwiches. However, GoodPop’s Cherry n’ Lemonade Pop
and Star Wars Green Apple Lightsaber Pops allegedly “consist largely of
fruit-juice concentrates and other additives, rather than whole fruit, juices,
or purees.” Aaccepting as true JonnyPops’s allegation that fruit juice
concentrate is not a type of whole fruit, juice, or puree, that was enough to
plead literal falsity; several cited reviews positively reference GoodPop’s
Cherry n’ Lemonade Pop being made with “100% real juice.”

Third, JonnyPops alleged that GoodPop uses images of
children eating its most sugary products to give consumers the misleading
impression that its products are healthy for children. No dice. None of the alleged
online reviews or comments were tied in any way to images of children in its
advertising.

Fourth, JonnyPops alleged that GoodPop’s packaging of its
products is “misleading and deceptive because [it] displays images of fruit
that are not the exclusive or even the primary ingredients of its products.” For
example, GoodPop’s Cherry n’ Lemonade Pop allegedly contains filtered water,
white grape juice concentrate, and apple juice concentrate as the top three
ingredients, as well as “some lemon juice” and “cherry … concentrate” as
lesser-included ingredient. JonnyPops cited a review that states, “I love the
mixture of the sweet tangy flavors from the lemon and cherry juice” and another
stating “You can taste the lemon and cherry in them.” [I’m reminded of research
indicating that vanilla ice cream tinted pink is perceived by many consumers as
strawberry-flavored.] Whether consumers instead understand the packaging to
show “critical ingredient[s]” was a fact issue to be resolved after discovery—just
as in the Pom Wonderful case.

The court found that it was plausible that consumers believe
GoodPop products only or primarily contain the fruit(s) depicted on the
packaging, thus making the packaging misleading for products where the fruits
in question are not the only or primary ingredient. However, “JonnyPops’s
argument that GoodPop’s packaging displays images of whole fruit but does not
contain whole fruit is borderline frivolous. As GoodPop argues in its Reply, ‘no
customer who sees whole cherries or oranges on a package expects to find stems
and peel in the product.’”

The court likewise denied the motion to dismiss
counterclaims based on product names. “It is plausible, for example, that
consumers are misled by a product being called Cherry n’ Lemonade Pop, when the
product contains more grape-based and apple-based ingredients than cherry-based
or lemon-based ingredients.”

Finally, JonnyPops alleged that GoodPop’s use of the “USDA
Organic” symbol on its packaging misleads consumers into believing its products
are healthy. A review of GoodPop’s Orange n’ Cream Pop, which contains eight
grams of added sugar stated that the reviewer felt “particularly good about
[this popsicle] because it is made of organic ingredients, no refined sugar or
high fructose corn syrup, and no artificial dyes.” Another consumer reported
that they “love the fact that these pops are organic, dairy free and isn’t
loaded with sugars and calories. Taste like the normal thing but way
healthier.”

Although I would have gone with preemption, the court found
that this wasn’t plausibly misleading. “JonnyPops does not provide the Court
with any facts supporting that GoodPops being labelled organic makes consumers
think anything other than what the label says—that they are organic…. If
JonnyPops’s argument is that a product can be both organic and unhealthy, which
is misleading to consumers, then that is an issue inherent with the USDA’s
definition of organic— not an issue with GoodPop’s particular use of the ‘USDA
Organic’ label.”

The California claims failed because JonnyPops didn’t plead
facts allowing the court to draw the reasonable inference that GoodPop engaged
in wrongful conduct in California or made false or misleading statements there.

from Blogger http://tushnet.blogspot.com/2025/11/pop-six-squish-do-both-popsicle.html

Posted in Uncategorized | Tagged | Leave a comment

Chicken feed virus protection claim triggers lawsuit

 Kalmbach Feeds, Inc. v. Purina Animal Nutrition, LLC, 2025
WL 3153412, No. 2:25-cv-00617 (S.D. Ohio Nov. 12, 2025)

One reason I love advertising law is that, eventually,
everything lands in it, and I learn about new-to-me corners of the world. Kalmbach
sued its competitor Purina for statements about Purina’s poultry feed products
under the Lanham Act and the Ohio Deceptive Trade Practices Act, and secured a
preliminary injunction on some of its claim.

Kalmbach’s “Henhouse Reserve” is aimed at the “backyard”
poultry market, as is Purina’s “Farm to Flock.” They are both granola-like
“premium” feeds aimed at owners who keep egg-laying hens. “Backyard chicken
flock owners tend to have fewer chickens; they may treat their chickens more
like pets and pay for premium feed. … Backyard owners may also be more
emotionally motivated to keep their chickens alive, because they might keep
their chickens as a hobby, for eco-conscious reasons, or because they view them
as their pets. Thus, they may be particularly concerned about recent avian
influenza outbreaks.”

Farm to Flock contains “FeedLock,” a “multispecies feed
additive technology” consisting of medium-chain fatty acids which are designed
to interact with the membranes of envelope viruses and “deactivate” them. “Although
medium-chain fatty acids have been found to help prevent outbreaks of disease
in swine, to date, there is no evidence that they impact disease outbreaks in
poultry.”

Nonetheless, for a month and a half in 2025, Purina actively
marketed Farm to Flock as “helping to defend against bird flu.” It based this
claim on (1) a lab test and (2) an assumption. For (1), Purina and its
codeveloper dosed four samples of chicken feed with varying levels of FeedLock
and H5N1, and one sample of control feed with H5N1 only. The FeedLock feed
“showed reduced viral loads” after twelve hours, while the control sample
showed stable levels of bird flu for a week. For (2), based on the “consensus
in the swine industry,” stemming from a commercial swine study, that
medium-chain fatty acids “inhibited the transmission of [swine envelope virus]
pathogens in the feed to” swine, Purina extrapolated that the medium-chain
fatty acids in FeedLock would similarly inhibit the transmission of the avian
influenza envelope virus pathogens to poultry.

Purina directly advertised its Farm
to Flock bird flu defense claims on its website and social media platforms, as
well as through direct communications to consumers and distributors across the
United States. Its employees, including scientists and sales representatives,
repeated variations of these claims on webinars and at in-person industry
meetings. In describing the purported flu-fighting properties of Farm to Flock,
Purina’s employees sometimes claimed it “has been shown to be protective
against, protecting against viruses…includ[ing] bird flu.”

one example of the virus defense claims; more below

Regulators in Kansas and Minnesota quickly raised concerns,
to which Purina responded by removing its claims and requesting that similar claims
made by third parties be taken down. The FDA subsequently identified an
additional statement that Purina needed to edit or remove, which it did. But Kalmbach, believing it had already suffered damage, brought suit.

The court considered the state and federal claims to have
identical standards.

Purina argued that claims like “helps defend against bird
flu” referred to defending the feed from becoming a transmission mechanism for
bird flu, not to defending the birds against bird flu. The court didn’t find
that a plausible reading. Anyway, such claims were “scientifically dubious,”
given that chicken feed was not known to be a transmission vehicle in the first
place; swine feed can be a source of transmission for viruses in swine, but
those swine viruses don’t affect birds. Its lab test didn’t show a decreased
risk of chickens contracting bird flu. Thus, the court found that the
statements about the impact of FeedLock feed on avian influenza were likely to
be found literally false.

Purina’s “immunity” statements were also literally false. Not
only did Purina tout its feed’s “Complete…Defense for Laying Hens” and
“Fun-filled, flu-fighting goodness” in large font at the top of the
advertisement, with the supposed caveat explaining that this defense relates to
the feed in small font at the bottom, even the caveat was false: “FeedLock® is
a breakthrough ingredient of the system that nourishes and protects, helping to
instantly defend your flock against avian influenza, while also boosting
immunity and breaking down harmful pathogens on the feed with every bite.” This
reference to “immunity” indicated that Purina was making claims both about FeedLock’s
interaction with avian influenza on feed, where FeedLock supposedly would break
down pathogens, and about avian influenza in a bird, where FeedLock would
supposedly boost immunity. Purina’s own expert witness testified that it was
“improper” to represent that FeedLock provides any “immunity or treatment
against avian influenza.”

ad claiming to support “immune, digestive & overall health”

And, given the expert consensus that feed is not recognized
as a “transmission vector of bird flu,” Purina’s “more ambitious” statements
that FeedLock defends against the bird flu, apart from any immunogenic function,
were also literally false. “If feed is not a known transmission vector—and
Purina’s laboratory test does not show that it is—protecting the feed could
have no impact on whether birds would get avian influenza.” At most, Purina’s
expert would only say that “[FeedLock] would definitely be able to interact
with that virus and break down the viral envelope,” which would then reduce the
infectivity of the virus to some extent—but she would not say that it could
“neutralize” the virus. Even in the lab, infected feed was only “approaching
nondetectable or approaching noninfective” once treated with FeedLock
(emphasis added). “Purina had no evidence showing Purina feed infected with
avian influenza, once treated with FeedLock, ever had a nondetectable or
noninfective amount of avian influenza.” And the feed tested in the lab was poultry
mash feed— “a ground feed different than Farm to Flock.” [Some parts of this
sound like “lack of substantiation” arguments, something that shows up later in
the remedy discussion, though taken together they plausibly add up to literal
falsity. In addition, given the scientific nature of the claims, it is reasonable
to treat them as “tests prove” claims, which means that they can be falsified
by showing that the tests don’t prove the ad claim.]

social media post

In addition, Purina necessarily implied false statements
about “defense against” bird flu.  E.g.,
claims that FeedLock “helps defend your flock….It helps to support strong
healthy hens by actively supporting and fortifying immunity and gut health” had
to be read in context with Purina’s claim in that same ad that
“FeedLock®…helps defend your flock against avian influenza and other viruses”
and claims that the feed “give[s] your hens the wellness boost they deserve
with layer feed that nourishes AND defends: [f]ortifies immunity and helps
defend against bird flu[,] [g]ut health support[,] [s]trong shells, vibrant
yolks.” These claims necessarily implied that the feed would defend the chicken
against bird flu after consumption, and that the feed gives the hens a wellness
boost.

“Every other claim in the ad (that the feed nourishes,
fortifies immunity, supports gut health, leads to stronger shells and vibrant
yolks) suggests a benefit to the hen, not the feed.” Thus, even assuming the
bird flu defense claim could technically/linguistically be about the feed, it
was false by necessary implication. “Purina cannot be heard to claim that this
one statement, buried among six about how Purina feed benefits the health of
hens, is about a benefit to the feed itself. It cannot be heard to say that any
claim that its feed fortifies immunity is unrelated to a claim that the feed
defends against viruses.” Purina’s proposed truthful meaning was not reasonable
and thus the claim could not be called ambiguous.  The court noted that other ads suggest that
the more FeedLock feed a bird consumes, the stronger its immunity becomes:
“FeedLock®…help[s] to instantly defend your flock against avian influenza,
while also boosting immunity…with every bite.”

“[S]ome of these ads plainly and facially imply that
FeedLock feed is defending or mitigating avian influenza in the chickens
themselves by ‘boosting immunity.’” Letters and inquiries from Purina’s
regulators confirm this implication.” (Among other things, the FDA took issue
with advertising statements about the bird flu that lacked “explicit reference
to the feed itself.”)

another ad

The ads also necessarily implied that FeedLock defended
backyard chickens more when more feed is consumed, and continued to defend
chickens even after consumption—by offering continuing immunogenic and health
benefits to the birds “with every bite.” The combination of immunity and health
claims along with claims that FeedLock feed “defends against” avian influenza
and other viruses “necessarily implies that FeedLock is providing some
antiviral value to the bird itself, including after consumption. Based on the
record, this appears to be false.”

So too with the necessary implication of statements claiming
benefits against “other viruses.” “Viruses,” plural, “necessarily and
unambiguously implies, in the context of an advertisement for ‘Hen Food,’ that
there are other viruses that FeedLock defends against.” Again, the record
supported falsity. “Avian influenza is the only virus known to infect birds.”

fact sheet (or is it?) claiming to fight “viruses like” bird flu

The court didn’t bother with misleadingness (though some
evidence shows up in the materiality discussion), because literal falsity can
be presumed deceptive. There was direct and indirect evidence of materiality:
direct from customer inquiries, which can show that a claim was
purchase-relevant, and indirect. “One of Kalmbach’s sales representatives
testified that she was told by customers and potential customers that they
wouldn’t consider Kalmbach’s Henhouse Reserve feed because it lacked a bird flu
preventative or bird flu prevention, unlike Purina’s Farm to Flock.” (Not
hearsay because not offered for the truth of the matter asserted.) Plus,
Kalmbach showed that Purina “misrepresented an inherent quality or
characteristic of the product.” Advertising virus defense is likely to induce
consumers to believe they are getting a better product than feed that does not
offer such a defense. Purina’s own internal consumer research results concluded
that such claims were “most motivating” to customers; Kalmbach’s expert
testified that many consumers in this market “are more emotionally motivated to
keep their chickens alive, and are concerned by recent outbreaks of avian
influenza,” and Purina’s expert agreed that backyard owners “are emotionally
connected to their flock.” Purina’s senior marketing manager testified that
Purina’s consumers “started to humanize or personify their chickens, and so
they treated them like family. They were more like pets like cats and dogs.” [I
hate to ask, but, based on this
story
, I have to wonder: is MAGA going to go after antivirals in chicken
feed? Will they worry about chicken autism?]

another example

The court pointed specifically to a Purina internal report
finding that the vast majority of consumers in the market found “brands that
spend time educating customers are more trustworthy,” [of relevance far beyond
this case!] and thought it was “important to stay up to date on the latest
nutrition for animals.” It did not follow that consumers would be skeptical of
such claims: “If anything, it seems logical that consumers would be less
inclined to scrutinize Purina’s claims because they would trust Purina,
believing that Purina’s efforts to educate consumers as to their feed’s
purported benefits were based on the latest updates in animal nutrition.” And
Kalmbach’s sales rep supported this by testifying that she told a potential
customer that the claim wasn’t true, and received the question: why would
Purina advertise it if it wasn’t true?

Causation/harm: “[T]o obtain injunctive relief[,] logical
likelihood of damages is sufficient.” Given the presumption of deception and
the existence of some evidence of misleadingness, including a consumer inquiry
into why Kalmbach does not “have a product like [Purina’s] that can defend
against bird flu,” Kalmbach was a likely victim of Purina’s acts.

There was a presumption of irreparable injury. Purina argued
that the presumption was rebutted here because any lost sales could be recouped
by money damages, and there was no evidence supporting “a more severe and
ongoing injury,” like a dealer dropping Kalmbach for Purina or reputational
damage. It also argued that requiring it to contact its customers would be too
extreme here, where there is no ongoing, irreparable injury.

Characterizing the issue as one of “presumption of harm,”
rather than presumption of irreparable injury, the court found that
there was still the distinct possibility that Kalmbach will suffer injury,
which is the wrong question, but the right one probably still has the same
answer. That’s because,

although Purina sent out three
blast emails to 130,000 recipients about Farm to Flock with statements
regarding avian influenza, it has never corrected those emails. Should any of
those 130,000 email recipients (or any further recipients of those emails) rely
on those emails, further disseminate those emails, or refer back to those
emails today or in the future, they may believe Purina still represents that
its Farm to Flock feed helps defend against bird flu. Because it would be
difficult, if not impossible, to calculate whether Purina’s more recent sales
of Farm to Flock were a result of these latent advertisements, calculating
damages would be futile.

Purina argued that Kalmbach’s supposed delay in bringing the
motion undermined any claim of irreparable harm. Kalmbach learned about
Purina’s advertisements in April and sued in early June; that wasn’t a
sufficient delay to undermine Kalmbach’s claim of irreparable injury,
especially given that Kalmbach would need some time to evaluate the scientific
claims.

Harm to Purina/balance of equities: Purina stopped further
publication but didn’t issue corrective statements. Purina argued that a public
retraction would risk damaging its reputation. At the preliminary injunction
stage, a court order proclaiming its ads were “unsupported and untrue” would
erode brand trust and goodwill, so that would be inappropriate. To be sure,
this was something of “a self-imposed risk” to Purina, so the court tailored
the injunction to avoid some of Kalmbach’s proposed harshness.

Purina initially consented to a mostly prohibitory
preliminary injunction: stop the accused advertising and notify distributors,
retailers, and marketing affiliates to cease use and dissemination of that
advertising. Kalmbach wanted Purina to publish a statement saying its claims
were untrue and that it was retracting them.

“Purina’s argument is mainly that requiring any public
statement on Purina’s part would be too extreme, and Purina points to cases
where courts ordered much more tailored relief.” The lesson was that “retractions
should be issued in instances where identifiable third parties received the
challenged claim,” and here those were emails. “Just because Purina has
addressed some forms of its prior advertisements does not mean that all
confusion will have dissipated. Thus, Purina must issue some form of a retraction.”

But the court would limit the language. The antivirus claim
was false “for the purposes of the Lanham Act and the Ohio Deceptive Trade
Practices Act because Purina had no empirical support or basis for it, and the
scientific consensus today suggests that it is incorrect.” But Kalmbach’s
expert testified that it is possible that avian influenza could live on
chicken feed, and that if a bird ingested that infected feed, that bird could
get avian influenza. And it was an open question whether FeedLock would have
any effect on avian influenza in bird feed, or the population of birds that eat
that feed. [It’s possible that sprinkling a mix of cinnamon and cumin
into the feed would protect birds; this is why the Third Circuit held that
making unsubstantiated claims that you have no reason to think are true counts
as making literally false claims. It’s bullshit in the sense that you have no
interest in the truth value of your claim; you’re just making it to sell the
product. And that’s not an attitude towards truth worth protecting even if
“lack of substantiation” claims are otherwise unavailable.]

But, anyway, this was a preliminary injunction and not a
final determination of falsity, so the court required the retraction (to be
sent to email recipients and posted on Purina’s website) to say “At the
preliminary injunction stage, the Court found that Purina engaged in false
advertising because these statements were not scientifically grounded and
lacked a scientific basis. Purina retracts these statements, as well as any
other representation that Purina’s Farm to Flock 18% Layer Hen Food defends
against, protects against, prevents, mitigates, or provides immunity to the
effects of avian influenza, bird flu, or other viruses.” [Quick TOS question:
does your TOS warn people who unsubscribe from your mailing list that you might
have to contact them in the future for legal compliance?] [Quick reading
comprehension question: what percentage of consumers will consider the reputational
hit to Purina decreased because it’s just a preliminary injunction? I think the
court did the right thing, but that doing so will not change the effects on
Purina’s overall reputation one jot. Which is to say that sometimes we should
be happily normative about these issues.]

Note: the court specified
URLs
at which the notice should be given, and they’re not there yet, but Purina
has 10 days, which (as of Nov. 14) have not yet passed. 

from Blogger http://tushnet.blogspot.com/2025/11/chicken-feed-virus-protection-claim.html

Posted in Uncategorized | Tagged | Leave a comment

Landing page that misdirected searchers away from real senior living community was plausibly false advertising

Cedar Communities at Commerce, LLC v. Caring, LLC, 2025 WL
3187288, No. 1:25-CV-00922-JPB (N.D. Ga. Nov. 14, 2025)

Caring operates a web-based senior living placement and
referral service, touting “the longest-running, highest-integrity senior living
review program on the web, all to ensure families make the best and most
informed choice possible for their loved ones.” Caring claims that it offers
“free, personalized guidance from experienced advisors who understand the
unique needs of seniors and their families” and that “Family Advisors provide
invaluable expertise to ensure you have all the information you need to
successfully find the community that meets all of your needs.”

Cedar argued that these statements were false and misleading
because (1) Caring exclusively refers potential customers to senior living
communities that are in its referral network, for which it earns commissions,
and (2) the service is not free, because Caring’s commissions are equivalent to
the first month’s rent and care and these costs are passed on to the customer
through higher rent and care expenses.

Cedar isn’t part of Caring’s referral network, but when
someone searches for “Brookside Commerce” (its dba) a “prominent listing” for
that appears on Caring’s site because of Caring’s SEO.

Google result

Cedar argued that this falsely implied that its facility was
part of Caring’s network; that the included photo is fake; and that the
3.3-star rating is phony. If a potential customer clicked on this link, they’d
go to a landing page tailored for Brookside Commerce, furthering the illusion
of network membership.

landing page

A click on “Request Tour,” “Get Costs” or “Find
Availability” would be connected to one of Caring’s representatives—not one of Cedar’s
representatives—who then directs the inquiry away from Cedar’s facility and to
a community within its referral network.

Cedar filed a putative class action for violation of the
Lanham Act and coordinate state law. The court declined to dismiss, saying some
things about false association that are worrying devoid of context but
understandable on these facts, and they are properly framed as false
advertising claims—requiring materiality (and commercial advertising).

Caring argued that claims like “comprehensive directories,”
“expert consultation” and “free referrals” were either non-actionable “puffery”
or true, and that Caring does not purport to offer “unbiased” consultations and
openly discloses its commission-based referral network model on the website.

Even without a specific statement about lack of bias, “after
viewing the statements as a whole and considering the full context of the
statements, the Court finds it plausible that a reasonable consumer under some
circumstances would be misled into believing that Defendant’s representatives
generate their recommendations in an independent, fact-based manner and select
possible options from the entire directory—instead of only promoting
communities in their network.”

What about the stock photo and user reviews?  Not really addressing those, the court agreed
that the landing page “creates a false impression of affiliation with” Cedar. Here’s
the yikes: “As an initial matter, it is reasonable to assume that some people
would think that Plaintiff’s facility was part of Defendant’s network simply
because the landing page exists on Defendant’s website.” More persuasively, “the
option to request a tour, get costs or find availability … give the false
impression to potential customers that they have the ability to easily obtain
additional information about Plaintiff’s facility by just clicking a button.
Importantly, however, when potential customers click on one of those buttons,
the potential customer is never provided with more information about
Plaintiff’s facility and is instead transferred to one of Defendant’s
representatives that recommends a facility that pays commissions to Defendant.”
(Note that if the buttons did work as labeled, even without affiliation, there
wouldn’t be falsity.)

Materiality: Cedar alleged that choosing a facility is a
“complex process” and that families and caregivers “often face overwhelming
stress and anxiety when trying to choose the right senior care option for their
loved one.” It was plausible that the website misrepresented “the inherent
qualities and characteristics of Plaintiff’s facility,” and Caring’s claim that
it offers expert recommendations “enhances the likelihood that [the]
misrepresentation would influence purchasing decisions” of potential customers,
especially where the decision making is complex and stressful.

Injury: Given the diversion from Cedar if consumers clicked
buttons requesting a tour, etc., that was plausibly pled, even without
identifying specific diverted consumers. Reputational injury was also plausible
because consumers may falsely assume that Caring’s alternative recommendations
(other assisted-living facilities) are superior.

State-law claims: Cedar argued that Caring’s keyword
“manipulation” violated state law against unfair business practices, and so did
the “unauthorized” landing page, leading consumers to believe the parties were
affiliated. Again, the court allowed the claims—even though keyword advertising
on its own is benign.

from Blogger http://tushnet.blogspot.com/2025/11/landing-page-that-misdirected-searchers.html

Posted in Uncategorized | Tagged , | Leave a comment

Fiskars can’t cut down $1.4 million disgorgement award

Fiskars Finland OY AB v. Woodland Tools Inc., 2025 WL
3124111, No. 22-cv-540-jdp (W.D. Wisc. Nov. 7, 2025)

Previously
in this false advertising case
the court sent to a jury part of Woodland’s
claim against Fiskars for false advertising, based on Fiskars’s statements
about the cutting power of its tools, and some of its statements that certain
products were designed in the United States. The jury sided with Woodland and
the court ordered disgorgement of about $1.4 million of Fiskars’s profits.
Here, the court denies JMOL to Fiskars as well as Woodland’s requests for
attorneys’ fees and prejudgment interest.

Fiskars argued that Woodland showed no evidence of harm,
such as diverted sales. There was no evidence of any specific lost sale, but
Woodland wasn’t required to present such evidence to get the equitable remedies
of injunction and disgorgement, only a likelihood of future injury. “The
likelihood of future injury is readily shown when the parties are direct
competitors and the false statement implicates the plaintiff’s product.” Here,
the evidence showed that the parties’ tools appearing side-by-side on the
shelves of some retailers. And 14.5% of Woodland’s survey respondents construed
Fiskars’s “3X More Power” claim to be a comparison to competitive products,
while Fiskar’s own expert testified that 43.9% of survey respondents considered
Fiskars’ cutting power claims in making their purchases. A reasonable jury
could find likely future harm.

As for the design origin claims, they were unambiguously
false. One of Fiskars’s witnesses testified that the design origin claims
didn’t resonate with consumers. But they were at least implicitly comparative,
and Fiskar’s survey found that 37.1% of survey respondents considered the
design origin claim in making their purchase of Fiskars tools. A reasonable
jury could also find likely future harm here.

Fiskars argued that the quantified cutting power claims weren’t
actionable statements of fact because they had no ascertainable meaning. Even
if this argument weren’t waived, the verdict was supported by substantial
evidence. A claim that Fiskars’s cutting tools were “powerful” might be
unquantifiable puffery, but “more power” implies a comparison with something
else. “That comparison could be tested and confirmed or disproven, even if the
claim is ambiguous because the object of the comparison isn’t stated.” “More
power” wasn’t “a completely vacuous or inherently subjective claim like ‘better,’
or even the resolutely ambiguous ‘local.’” And adding the quantifier “3X more
power” “suggests an even more specific comparison that has somehow been
measured or calculated.” People didn’t have to know exactly how to believe it.

The survey evidence “showed that a substantial number of
respondents took the cutting power claims to mean three times more power in
comparison to competitive products.” But this wasn’t true. Fiskars’ evidence
showed that the original comparison was between Fiskars’s mechanically
advantaged tools and single-pivot tools. Although the claim was ambiguous, a
significant number of prospective purchases interpreted the cutting power
claims to be a reference to competitive products, and that interpretation was
false.

 

Fiskars argued that Woodlands didn’t test enough different
products to show that the claims were false as to all. But given the origin of
the claim in a comparison with single-pivot tools, there was no reason to think
that Fiskars could support the claim that its tools were better than
mechanically advantaged tools. (This is perhaps an understandable instance of
burden-shifting, at least with respect to the burden of production, or an
adoption of the Third Circuit rule that making a claim that you have literally
no reason
to think is true constitutes falsity.)

Materiality: Although one Fiskars witness testified that
neither the cutting power claims nor the design origin claims resonated with
consumers, there was “ample testimony” that Fiskars invested a lot in touting
its cutting power claims. A retailer requested “aisle violators” promoting the
3X claims, suggesting that it regarded the cutting power claims as important.
Woodland employees, who used to be Fiskars employees, testified about the
importance of the claims; the jury could have found them to be biased, but it
didn’t have to. And Fiskar’s survey could also be used to show materiality: 43.9%
and 37.1% were “alone” enough to suggest materiality.

Fiskars’ survey also asked respondents what factors were
important to the purchasing decision, asking them to allocate 100 points among
them. Cutting power scored an average of 7.7 points; design origin scored an
average of 5.5 points. Fiskars argued that these scores were too low to find
materiality, but “manufacturer or brand name” was the factor ranked third
highest among the nine options, and it only scored an average of only 10.1. Although
other factors accounted for an average of 86.8 points, the expert didn’t
testify that cutting power or design origin were irrelevant, and the jury could
weigh the survey in Woodland’s favor.

Still, this wasn’t an exceptional case, just a thoroughly
litigated one; no fees (or prejudgment interest). On the patent claims,
Woodland argued that Fiskars made little effort to investigate its claims and
brought this case as an illegitimate effort to quash legitimate competition,
promising to go after Woodland Tools with “scorched earth” tactics using the
world’s largest law firm. “The case had a David and Goliath feel to it, due
mainly to the relative size of the parties. And there’s no doubt that Fiskars
pursued the case aggressively.”

Still, the court found Fiskars’s outrage “understandable”
because Woodland Tools was founded by former Fiskars employees, and there was
some evidence that “some of those employees were laying the groundwork for the
new competitor while they were still working for Fiskars. Some of the employees
left with Fiskars work product and software code.” Although Woodland prevailed
on these claims at summary judgment, “that doesn’t mean that the actions of
Woodland Tools employees were unimpeachable, or that Fiskars pursued legal
action out of pure spite. Part of Fiskars’s goal was to impede competition from
Woodland Tools, but that’s an ordinary and lawful purpose of litigation over
trade secrets and intellectual property.”

The court didn’t award Lanham Act fees because it assessed
reasonableness in the overall context of this case, which featured multiple
claims.  Woodland’s “success in showing
willful false advertising based on the 12 cutting power claims and one of the
design origin claims [was] a small part of a much larger case.” And, though
Fiskar’s false advertising was willful, it wasn’t particularly egregious. The
cutting power claims weren’t literally false, and only a minority of survey
respondents interpreted them as a comparison to competing products or found
them material. Nor was Fiskars’s litigation conduct exceptional.

Prejudgment interest: Under the Lanham Act, there is a
presumption that “victims of violations of federal law” are awarded prejudgment
interest, but the decision is ultimately committed to the discretion of the
court. The court would have awarded prejudgment interest for damages reflecting
the time value of the money, but not for disgorgement in the absence of actual
damages. Prejudgment interest would be a penalty, not compensation.

from Blogger http://tushnet.blogspot.com/2025/11/fiskars-cant-cut-down-14-million.html

Posted in Uncategorized | Tagged , | Leave a comment

Star Wars mod wars: claims over a touted but unreleased mod have to go to trial

Mickelonis v. Aspyr Media, No. 8:23-cv-01220-MWC-ADS, 2025
WL 3050071 (C.D. Cal. Oct. 2, 2025)

Interesting video game related dispute: Aspyr develops video
games, including by recreating and re-releasing historic games on modern
platforms like Steam and Nintendo Switch. Aspyr has a longstanding relationship
with Lucasfilm to release historic Star Wars games, including Knight of the Old
Republic II: The Sith Lords (KOTOR II). Players adopt the personal of a Star
Wars character and guide that player through a storyline.

Many games allow players to add their own content, including
maps, designs, and other features. Gameplayers also release new, unofficial
content, called “mods” or “downloadable content.” “The game studios that
release these games are not the designers of these mods, and the mods often
have gameplay or other issues.” Years after KOTOR II’s 2004 release on Xbox, a
group of modders discovered previously unreleased code in the game itself and
created the mod at issue here; the group included programmers, fans who
supplied new voice-overs, and others. Aspyr characterized the mod as involving
“a few new characters and an alternate ending,” while plaintiffs argued that
the mod had “a significant amount of unreleased and unfinished content,” which
the modders “unlock[ed], fill[ed] out, debug[ged], and complete[d] … ,” including
“expanded locations, new dialogue and voices, new character interactions, and
even a new planet.”

Aspyr re-released KOTOR II for Steam, Nintendo Switch, Xbox,
and others in 2017. When re-releasing KOTOR II for Steam, Aspyr negotiated with
the developers of the Mod for them to release the Mod at the same time; the Mod
would be free on Steam, just as it had been when the developers released it in
the early 2000s. Aspyr also contacted the modders, who signed a formal release
on behalf of the developer group, for free release on the Switch. The parties
disagree on what happened next.

Aspyr’s Star Wars games historically cost between $9 and $15
to consumers. As for marketing,

 Many of KOTOR II’s users are drawn to the game
because of Star Wars, rather than a general interest in video games. Accordingly,
when marketing to those consumers, Defendant focused on emphasizing the Star
Wars theme and the Lucasfilm logo. Other users were more focused on KOTOR II’s
game type—a first-person, choose-your-own-adventure story, and the bulk of
Defendant’s advertising focused on these users. That advertising included a
YouTube video showing actual gameplay and describing the game’s story.

One of its YouTube videos had, in the final four seconds, an
announcement reading “Coming Soon: Restored Content DLC.” Nintendo posted the
same trailer on its e-shop for KOTOR II where consumers would purchase the
game. Aspyr tweeted about the Mod and referred to it publicly multiple times. It
released a version of KOTOR II for Nintendo Switch while the release of the Mod
was still pending. And then, as the existence of this litigation signals, it
didn’t release the Mod, apparently because Lucasfilm got cold feet/wanted
releases from people who weren’t findable. During the attempt to reach agreement,
a higher-up told people that “all marketing activity should be paused,” but the
marketing team did not remove several ads, including the YouTube video
announcing the release and various tweets.

Thus, in June 2023, Aspyr announced that it couldn’t release
the Mod and offered a free game to maintain customer loyalty. It sold 160,000
copies of KOTOR II worldwide.

Plaintiffs provided evidence that some consumers were
motivated by the Mod, e.g., “They knew no one would buy it without the [Mod]”
and “Restored Content DLC? That’s really good, more than what I expected…
Serious?! Even the current Xbox version doesn’t have it. I might need to buy
it… If that’s true it’s a must buy to me,” and then “Fuck Aspyr for not
offering us refunds and for straight up bait and switching us (which is illegal
by the way)” and “Free game key. How about a refund guys. This was one of the
key selling points of the port, a lot of people only bought it because they
expected the [Mod].”

Plaintiffs submitted expert reports indicating that economic
damages could be readily determined and that the Mod was likely material. Aspyr
provided countervailing expert reports contesting these points. Hal Poret surveyed
over 300 individuals who played KOTOR II for Nintendo Switch and found that
96.3% of respondents stated that they were satisfied with the overall purchase,
while 1.7% said that they were dissatisfied, and that “[w]hen asked for all the
reasons that come to mind for why respondents were satisfied or dissatisfied
with their purchase of the game, 0.7% of respondents (2 out of 300) mentioned
anything having to do with restored DLC.” Asking people about satisfaction with
something they’ve paid for runs into significant problems of post-purchase rationalization;
plaintiffs’ expert also argued that the survey “suffer[ed] from a severe
validity issue, that is, it failed to measure what is supposed to
measure—material impact of the ‘deceptive’ and ‘false’ advertising message
about the Restored Content DLC upon relevant consumer’s intention to purchase KOTOR
II,” with “an invalid measurement of materiality, an incorrect definition of
universe and a major leading question.”

Although the court denied class certification under the laws
of a number of states, the case continued.  

The court declined to grant Aspyr summary judgment on
materiality, since a reasonable jury could reject Poret’s study. Aspyr argued
that the plaintiffs were a weird, small segment of the buying public, not
reasonable consumers, but plaintiffs’ own testimony plus the online comments
would let a reasonable jury decide otherwise. The court noted that, “[i]n
determining whether a statement is materially misleading under California law,
the primary evidence … is the advertising itself.” “Given that the last image
that anyone viewing the announcement YouTube video saw were the words ‘Coming
Soon: Restored Content DLC,’ and that [redacted] [ed. note: argh!], a
reasonable jury viewing the advertisement could also find materiality based on
its contents.” Although “materiality depends on the perspective of the
consumer, not the perspective of the defendant,” the advertising itself was
evidence.

Standing: Aspyr argued that, because the plaintiffs couldn’t
prove that the Mod had any economic value, they lacked standing. Again, this
was a contested material issue.

Injunctive relief: Aspyr argued that it had ceased marketing
the Mod, but plaintiffs pointed to persisting online traces claiming that the DLC
was “coming soon” on “affiliate platforms that it controls, including IGN and
Gamespot.” The evidence that Aspyr controlled these sources was “limited,” but
Aspyr provided no counterevidence and thus couldn’t get summary judgment.

Aspyr then argued that it lacked the requisite knowledge
until March 2023, when Lucasfilm told it that Lucasfilm wouldn’t approve the
release. It argued that the laws of California, Oregon, South Carolina, and
Colorado required knowledge of the deception, or at least negligence (for
California). For claims seeking injunctive relief under the California UCL, the
court found knowledge unnecessary, while the CLRA does require knowledge (for
damages). There was a genuine dispute of material fact about Aspyr’s knowledge.
There was evidence that, when it started advertising, Aspyr lacked approval,
and “Coming Soon” could confuse the public into believing that the game would
certainly have a DLC, “when there remained a distinct possibility that the DLC
would never receive approval.” A reasonable jury could conclude that the ad was
knowingly false.

Oregon: “[D]efendant[’s] representations violated the
[Oregon] UTPA only if, at the time that they were made, defendant[ ] knew or
should have known that [its] services did not have the qualities defendant[ ]
represented them to have.” There was also a genuine dispute here.

South Carolina:  The
plaintiff from this state alleged that he bought the game before it was available
for purchase, so the claim failed regardless of the legal standard around knowledge.

Colorado: “[a] CCPA claim will only lie if the plaintiff can
show the defendant knowingly engaged in a deceptive trade practice.” Thus,
Colorado’s consumer protection law “provides an absolute defense to a
misrepresentation caused by negligence or honest mistake,” meaning that
liability “is dependent upon knowledge or intent existing at the time of the
advertising conduct and the remediable damage that results from that conduct.” Still,
there was a genuine dispute of material fact.

Reliance: Plaintiffs’ declarations that they saw the
marketing materials sufficed to create a genuine dispute of material fact.

Texas: Plaintiffs failed to give the required notice under
Texas consumer protection law before suing.

The court also denied plaintiffs’ motion for partial summary
judgment on falsity. “Viewing the evidence in the light most favorable to
Defendant, Plaintiffs have not offered sufficient evidence to show that they
were reasonable consumers rather than consumers with specialized knowledge.” And
they didn’t satisfy their burden to prove that the statements were false when
made; a reasonable jury could find that “Coming Soon” wasn’t false “based on
the progress that had already been made in obtaining approvals to release the
DLC, including its receipt of approval from the ‘Mod leaders.’”

from Blogger http://tushnet.blogspot.com/2025/11/star-wars-mod-wars-claims-over-touted.html

Posted in Uncategorized | Tagged , | Leave a comment

Reading list: consumer protection and the industries who regularly sue their regulators

Nicholas R. Parrillo, Administrative Law as a Choice of Business Strategy: Comparing the Industries Who Have Routinely Sued Their Regulators with the Industries Who Rarely Have

George Washington Law Review, Vol. 93, No. 5, pp. 1031-1195 (2025) 
Abstract:

For some large and powerful industries, it has long been normal and
even routine for businesses to sue their federal regulator. For other
large and powerful industries, it has been rare for the last twenty-five
to forty years or more. This variation is enormous yet almost entirely
unknown to the literature on administrative law.

This Article
documents and analyzes this variation in one type of federal regulation:
public health and safety. For every major federal health-and-safety
regulator, I search dockets to identify every judicial challenge to the
agency’s actions brought by the agency’s principal regulated
industry—whether by individual companies therein or by trade
associations—during the period from 2013 to 2021 and, for several of the
agency-industry pairings, for additional time periods extending as far
back as the 1980s and as recent as 2024. The pairings covered are the
following: the Food Safety and Inspection Service at the U.S. Department
of Agriculture and meat and poultry processors; the Food and Drug
Administration and drugmakers; the National Highway Traffic Safety
Administration and automakers; the Federal Aviation Administration and
airlines; the Consumer Product Safety Commission and children’s product
companies; the Nuclear Regulatory Commission and nuclear plant
operators; the Occupational Safety and Health Administration and
employers generally; the Mine Safety and Health Administration and coal
mines; the Environmental Protection Agency and power companies; the
Federal Motor Carrier Safety Administration and for-hire trucking
companies; and the Centers for Medicare and Medicaid Services and
hospitals and nursing homes. For each pairing, I use the data on
judicial challenges as the starting point for a qualitative discussion
of how big or small a role litigation plays in agency-industry
interaction.

I find that industry judicial challenges tend to be
few and marginal when two conditions are met. The first condition is
that companies in the industry have a thick relationship with the
regulator—that is, each company knows the regulator will be making
repeat decisions impacting its business into the indefinite future, so
each company has a stake in winning the agency’s trust and goodwill. The
second condition is that, with regard to the agency action at issue,
industry economic interests are aligned with the mission of the
regulator. This is especially the case for agency action that has the
official purpose of protecting the health and safety of the industry’s
own consumers, as opposed to protecting industry workers or victims of
externalities of industry conduct. In protection of consumer health and
safety, the industry and the regulator are more likely to view each
other as on the “same team,” and industry tends to (1) see the regulator
as a source of credible guarantees that help attract business, (2) fear
the “bad look” with consumers that conflict with the regulator could
cause, and (3) seek influence and leverage over the agency by less open
and adversary means than litigation. 

from Blogger http://tushnet.blogspot.com/2025/11/reading-list-consumer-protection-and.html

Posted in Uncategorized | Tagged , , | Leave a comment

claims about game provider’s bot use in “fair” and “skill-based” games must go to trial

Skillz Platform Inc. v. Papaya
Gaming, Ltd., 2025 WL 3012836, 24cv1646(DLC) (S.D.N.Y. Oct. 27, 2025)

Most recent previous opinion discussed here.
Skillz sued its competitor in the “real-money skill-based mobile gaming” market
for violating the Lanham Act and NY GBL § 349 by stating or implying that its
games pit human players against each other when in fact Papaya employed bots
against human players. Here, the court denies summary judgment to Papaya.

“In RMSB games,
players are matched by the platform with other users on games created by third
parties and compete to win cash prizes or for game rewards.” Skillz most
commonly offers head-to-head competition between two players, while Papaya
offers multi-player tournaments with larger cash prizes. In various ads, Papaya
has described its games as “fair” and “skill-based,” represented that Papaya
has “no vested interest” in and does not “profit” from who wins or loses its
tournaments, and refers to “players” “over the age of 18,” “individuals,” and
“winners” as the users on its platform. Its video ads showed images of humans
playing games, and claimed that its games “are directly determined by your
level of skill” and that Papaya will “match [you] against players with similar
skills.”

It was undisputed
that Papaya used bots in its games from 2019 until at least November 2023. Its
liquidity bots filled in user slots to ensure that a tournament “won’t stay
open for too long” as it awaits players. Its tailored bots were used to create
“a predetermined outcome” where Papaya “want[s] the player to finish at some
predefined rank,” which requires “control[ling] the scores of the rest of the
players.” All players in a tailored-instance outside the ‘receiving’ player”
are bots. “Papaya customers inquired between 2021 and 2023 whether they were
playing against other human beings or against a computer or a bot. Papaya’s
responses generally emphasized that it matched players with similar skill
levels and assured the complaining customers over 200 times that ‘we do not use
bots.’” Papaya even closed the accounts of two players who expressed suspicion
about Papaya’s use of bots.

Papaya regularly
identified Skillz as its largest direct competitor and benchmark for
performance assessments. During Papaya’s bot era, Skillz saw a decrease in
market share while Papaya saw an increase.

Papaya argued that Skillz
lacked sufficient evidence that any of its advertising statements communicated
a false message to consumers, were material, or caused Skillz injury. The court
disagreed.

A reasonable jury
could find literal falsity or falsity by necessary implication, leading to a
presumption of deception. Papaya’s representations that its tournaments are
“fair,” “skill-based,” and only between “players” and “individuals” who are
“over the age of 18” could be false based on the undisputed evidence of bot
use. Similarly, statements that Papaya has “no vested interest” in who wins or
loses, and that it does not “profit on the outcome of a Tournament,” could be literally
false because there is evidence that Papaya used bots to control the outcomes
of tournaments (and speed them up so players could use their winnings on new
games). [Frankly, I’d be inclined to grant summary judgment to Skillz on
falsity!]

Papaya argued that it
never expressly stated in its advertisements that there were no bots in its
games. “The issue is what a reasonable consumer would understand Papaya’s
statements to mean. Should a jury find, for instance, that the advertising
necessarily and unambiguously implied that only human players competed in
Papaya’s games, it would be entitled to find that the advertising was literally
false.”

Papaya argued that
“skill-based,” “fair,” “players,” and “individuals” were not literally false
because those terms had multiple meanings. [Insert goose meme: what meanings?
What ones???]. The jury could find that, in context, they were literally false
or false by necessary implication. Papaya’s expert concluded that skill played
a greater role than chance in the outcome of Papaya’s tournaments, regardless
of bot usage. So what? It was undisputed that Papaya used tailored bots to
control the outcomes of tournaments. Papaya “could prevent players from winning–or
allow them to win–no matter how they performed in the game.”

Papaya also argued
that its statements that it had “no vested interest” in and did not “profit” on
tournament outcomes were accurate, because Papaya made less money in sessions
with bots because bots do not pay entry fees. Its experts opined that human
players received more in total cash prize awards due to Papaya’s use of bots. That
was a jury question. [Seems pretty inconsistent with the profit motive—did
human players walk away with more money total because of bots, or did they play
more games/stay longer?]

Implied falsity: This
can be shown through either “extrinsic evidence of consumer confusion” or
“evidence of the defendant’s deliberate deception,” the latter of which must be
“egregious” to “create[] a rebuttable presumption of consumer confusion.”

There was
sufficient evidence for a reasonable jury to find deliberate deception, given
Papaya’s repeated denials of bots’ existence. E.g., when one player asked, “Is
every single player I play against in a tournament a real player or are there
computers playing at times?”, Papaya responded, to “clarify that we do not use
bots or computer players” and that “if it were possible to control [tournaments]
manually, it would not be fair to other players.” Papaya CSRs were instructed
to escalate any complaints that referenced bots to management, and one employee
stated that a customer service representative “displayed poor judgment” by
keeping open an account of a consumer who had complained about bots and
demanded a refund. Papaya had an internal policy of removing posts in its
Facebook group that mentioned bots.

Papaya argued that
there should be no presumption of deception because Skillz failed to provide
evidence that any intent to deceive was linked to a specific challenged
statement. But internal statements by executives and the company’s awareness of
consumer confusion, among other things, are relevant to intent. Here, there was
evidence that Papaya and its executives recognized that its use of bots “did
not align” with its public statements and that this “misalignment” confused
customers.

Indeed, executives
decided to respond to a consumer who asked for a direct answer on whether
Papaya used bots by informing the user that the platform has “real players” and
placing the blame on “rare cases where players use automated systems.”
Recognizing that consumers noticing bots on the platform was a growing issue
and impacted “trust in our fairness,” Papaya executives modified its bots’
performance to make bot profiles appear more human so that fewer users would
detect their usage going forward. Another employee stated: “While understanding
the need for bots, the margin of their winnings should be smaller and less
obvious to our players.” A reasonable jury could find intentional deception,
despite the testimony of Papaya’s Rule 30(b)(6) witness, who stated that
instances in which Papaya told customers that it did not use bots were “an
unfortunate mistake” committed by the customer support vendor and “not Papaya’s
position.” The court noted that “Papaya’s executives have not made similar
representations. They invoked their Fifth Amendment privilege to remain silent
during their depositions and have not offered affidavits in support of this
motion.” [Yikes.] Regardless, there was enough to go to a jury.

Skillz also offered
extrinsic evidence of consumer confusion created by Papaya’s use of the terms
“skill-based,” “fair,” “players,” “winners,” “individuals,” and “no vested
interest,” in its advertising. Along with individual consumer responses, Skillz
provided survey evidence.

Respondents had
played at least one of four games that Skillz and Papaya offer on their
platforms. Upon watching a Papaya ad, 45.8% of respondents indicated that they
believed that the game used solely human players. The survey next presented
respondents with a mock app store description constructed from Papaya’s public
statements:

Solitaire
cash makes sure to match players against other opponents with a similar skill
level to ensure a fun and fair experience for everyone. You’ll be matched with
other players within the same skill level, and you will get the same deck – so
the game is totally fair and skill-based. The outcome of Solitaire cash is
based on the skill of the players, rather than luck or chance. Solitaire cash
has no vested interest in who wins or loses, nor does it profit on the outcome
of a tournament that we provide.

After reading the
description, 60% of respondents indicated that they thought the game included
only human players.

Papaya argued that
the survey was inadmissible because it did not use a control, stripped the
statements to which respondents reacted of their “real world” context, and did
not survey the appropriate populations, excluding prospective game players and
thereby including too many men. These were issues for cross-examination, not
demanding exclusion.

Papaya didn’t
explain what kind of control could have improved the survey’s reliability.
[This is a missed opportunity! A control ad could have just described the game
mechanics and not the opponents and tested whether consumers thought they’d
received any message about whether they were playing against other humans. I
wouldn’t be at all surprised if the net confusion levels were still pretty
high, given the explicit claims. Still, the court didn’t appear to understand
the purpose of a control: “The survey is designed to test the impression
created by the words Papaya chose to describe its games. Testing responses to
statements that Papaya did not use in its advertising would be neither relevant
nor illuminating.”]

Papaya also argued
that the survey wrongly screened for past players of RMSB games, not
prospective consumers to whom the ads were directed towards, who differed
demographically. Skillz’ expert filed a supplemental report looking at what
happened when he removed randomly selected male respondents to match the ratio
of male to female respondents in Skillz’s own survey of Skillz’s actual
customers. The differences were, he reported, statistically insignificant.

Materiality: While
the materiality of the falsity and the injury to the plaintiff resulting from
the defendant’s falsity are “separate essential elements … where the
defendant and plaintiff are competitors in the same market and the falsity of
the defendant’s advertising is likely to lead consumers to prefer the
defendant’s product over the plaintiff’s,” proof of injury to the plaintiff may
also demonstrate the materiality of the falsehoods.

Skillz relied on
evidence that consumers complained to Papaya and closed their accounts with
Papaya when they came to believe that Papaya was using bots in its games, as
well as on Papaya’s efforts to deceive consumers about its use of bots. It also
offered a second survey that sought to measure the likelihood of consumers
continuing to play if they learned that some of their opponents in real-money
games whom they thought were human were actually bots.

Half
the respondents were randomly asked if they would “continue” to play if they
were informed that some of their opponents were bots, and the other half were
asked if they would “stop” playing. Of the former group, 51.2% of respondents
indicated they would be unlikely or very unlikely to continue playing. Of the
latter, 66.8% indicated they would be likely or very likely to stop playing.

[It seems to me
that with less evidence of deception, that amount of a swing (over 15% of
respondents) from a small wording change would be concerning—but frankly, even
if you take 51.2% as a midpoint and say that it might reflect only a range from
35%-66% materiality, those are big enough numbers that it shouldn’t matter.
Which is also to say that I’m not sure that you should draw anything but
qualitative conclusions from surveys like this. Also:]

The survey had a control: half the
respondents were also asked if they would continue playing – with the other
half being asked if they would stop – if they were informed that they had to
wait one hour to learn the results of the game. Here, the numbers were 40.8% (unlikely
or very unlikely to continue playing) and 54.8% (likely or very likely to stop
playing), suggesting that the wording affected about 15% of respondents, which
with these numbers didn’t matter much. “At bottom, regardless of how the question
was phrased, a significant number of respondents showed a propensity to cease
playing when they learned there were bots in the games.”

Papaya argued that the survey didn’t measure the materiality
of bots, but rather the materiality of learning of intentional deception. That
went to the weight of the survey, not its admissibility. [Especially if there
was intentional deception!]

Papaya also argued that bots are so ubiquitous in the
industry that consumers “fully expect” them to be deployed, and that its
failure to disclose was in line with industry practice. “These arguments fail
to engage with the evidence of deception and materiality offered by Skillz.”

Injury: Injury “can be established when defendant and
plaintiff are competitors in a relevant market and plaintiff demonstrates a
logical causal connection between the alleged false advertising and its own
sales position.” Papaya regularly identified Skillz as its largest competitor
and benchmark for performance assessments, and Papaya’s growth in market share
in 2021 coincided with Skillz’s decline in market share. “Even if Skillz were
unable to quantify its damages with sufficient certainty to recover those
damages, it could seek injunctive relief and disgorgement of the defendant’s
ill-gotten profits.” And Skillz offered an expert to calculate both damages to
Skillz and Papaya’s unjust enrichment, the latter of which was between $650 and
$719 million, depending on whether that profit was measured by Papaya’s cost
savings from its use of bots or by how much less it would have earned without
deception. That report was admissible and relevant.

Papaya argued that “the but-for world in a false advertising
case must be one in which the false statements were never made and cannot be
one in which the accused business practice did not occur.” But the expert’s
choice was not unreasonable. “There is evidence that Papaya may not have been
able to operate in the RMSB marketplace at all if it publicly and accurately
disclosed its use of bots.” If it did so, it might have been classified as a
gambling platform by app stores—unlike RMSB platforms, gambling platforms hold
a stake in the results. RMSB games don’t involve “playing against the house”
and are supposed to collect the same revenue regardless of who wins, whether
from entry fees, advertising revenue, or in-app purchases. “[H]ad Papaya disclosed
its use of bots, Papaya may have been faced with the regulatory and tax
requirements with which gambling platforms must comply. In addition, it may
have lost access to app stores and payment processors and have been excluded
from the RMSB market.”

GBL claims survived for the same reasons.

from Blogger http://tushnet.blogspot.com/2025/10/claims-about-game-providers-bot-use-in.html

Posted in Uncategorized | Tagged | Leave a comment

bad Lanham Act claim, swept up with bad patent claim, triggers Rule 11 sanctions

Raydiant Oximetry, Inc. v. ALC Medical Holdings LLC, —
F.Supp.3d —-, 2025 WL 3022882, No. 25-cv-00392-VC (N.D. Cal. Oct. 29, 2025)

Baseless patent and false advertising claims produce a big
Rule 11 award. The patent stuff is eye-popping, and it’s hard to imagine that
Rule 11 would have been appropriate just for the false advertising claim, which
was baseless only because the challenged statements didn’t occur in “commercial
advertising and promotion”/weren’t part of an organized campaign to penetrate
the market. But still—a warning!

I’ll let the court introduce the facts:

This dispute began when ALC Medical
Holdings sent Raydiant Oximetry a demand letter alleging that Raydiant’s
medical device [a uterine device used to treat postpartum hemorrhaging] infringed
ALC Medical’s patent. This accusation was false. Raydiant’s device has a
“placement marker” that is permanently affixed, while the device claimed in ALC
Medical’s patent requires an adjustable placement marker. In fact, the Patent
and Trademark Office declined to approve the patent application until it was
narrowed to require that the placement marker be adjustable.

Unfortunately, patent plaintiffs
send baseless demand letters to defendants with some regularity. But this was
no ordinary fishing expedition. To the contrary, all evidence available to ALC
Medical and its lawyers at the time they sent the letter pointed strongly
towards noninfringement. The sole founder of ALC Medical, Jennifer West, used
to work at Raydiant. She helped develop Raydiant’s device and knew that it did
not have a moveable placement marker. There was a reason for this design
choice: Raydiant concluded that if the device’s placement marker were moveable,
it would be dangerous to the patients who use it. Presumably for the same
reason, the device West developed after she left Raydiant does not contain a
moveable placement marker, even though her company’s patent requires one.

Thus, when Raydiant brought an
action in this Court seeking a declaratory judgment of noninfringement, ALC
Medical and its lawyers should have apologized and walked away.… Instead, they
doubled down. They brought counterclaims against Raydiant, including one for
infringement, asserting again that Raydiant’s device possessed a moveable
placement marker. They also falsely alleged that West’s own device practiced
the invention—that is, that her device had a moveable placement marker.

In support of the infringement
counterclaim, ALC Medical and its lawyers submitted several diagrams depicting
Raydiant’s device. On each diagram, they cited the YouTube video of a
presentation Raydiant gave at an industry conference, indicating that the diagrams
originated from the slide deck used in that presentation. But that was not
entirely true. The lawyers manipulated one of the diagrams, superimposing
dotted lines to make it seem like Raydiant’s device had a moveable placement
marker. Nothing in Raydiant’s actual slide deck or the video of the
presentation suggested that was the case.

Subsequently, Raydiant allowed ALC
Medical and its lawyers to inspect the device. The inspection confirmed what
all the evidence had previously suggested: the placement marker was not
moveable…. ALC Medical and its lawyers … embarked on a ham-fisted scramble to
avoid liability for Raydiant’s attorneys’ fees. First, they refused to dismiss
their infringement counterclaim (or their equally frivolous false advertising
counterclaim) unless Raydiant also agreed to dismiss its declaratory judgment
action, with each side to bear its own fees and costs. Naturally, Raydiant
refused. Then, ALC Medical and its lawyers filed a frivolous motion to dismiss
Raydiant’s declaratory relief action for lack of jurisdiction, claiming falsely
that Raydiant’s device was an “investigational device” immune from infringement
claims. Later, they cobbled together a covenant not to sue that they argued
mooted Raydiant’s declaratory relief claim, even though it clearly did not. At
each step of the way, the position taken by ALC Medical and its lawyers became
increasingly disconnected from the reality of the situation ….

Raydiant was awarded over $1.4 million in attorneys’ fees,
with ALC Medical and its law firm Womble Bond jointly and severally liable.

The false advertising counterclaim was based on Raydiant’s
presentation of its device at the Stanford Medicine Pediatric & Maternal
Innovation Showcase, a pitch competition. Sanctions are warranted under Rule 11
if “(1) ‘the [challenged pleading, written motion, or other paper] is legally
or factually baseless from an objective perspective,’ and (2) the attorneys
failed to conduct ‘a reasonable and competent inquiry before signing and filing
[it].’ ” The court found that both counterclaims “easily [met] this test.”

Just a bit from the patent discussion: Womble Bond denied
bad faith in submitting the altered exhibit, asserting that the annotated
dashed lines were made with a different font and in red color to distinguish
the exhibit from the original slide. “This is difficult to swallow,
particularly because counsel only submitted a black and white copy of its
counterclaims to the Court, and the two fonts apparently used on [the exhibit]
are not easily distinguishable. If Womble Bond and ALC Medical had truly been
concerned about not misleading the Court, as opposed to disguising the
baselessness of the infringement counterclaim, they could have easily included
a disclaimer alongside the image clarifying that it had been annotated.”
Practice tip ahoy!  

The Lanham Act counterclaim alleged that Raydiant’s
discussion at the pitch session of its device’s being “cleared” or “approved”
by the FDA was misleading because the device is a Class II device exempt from
premarket notification requirements. “ALC Medical and its counsel knew or
should have known that the claim was objectively baseless under Ninth Circuit
law,” because only “commercial advertising or promotion” is actionable under 15
U.S.C. § 1125(a)(1)(B). This requires: (1) commercial speech; (2) made by a
defendant who is in competition with the plaintiff [note that this is not
necessary post-Lexmark]; (3) for the purpose of influencing consumers to
buy the defendant’s goods or services; and (4) “disseminated sufficiently to
the relevant purchasing public to constitute ‘advertising’ or ‘promotion’
within that industry.” A presentation at a one-off grant competition, “clearly”
does not constitute “commercial advertising or promotion” under that
definition. The court distinguished cases involving a press release and a
conference presentation whose slides were posted on the defendant’s website.
The pitch competition was more akin to “private statements made to actual and
potential customers” that were insufficient to constitute sufficient
dissemination. Thus, the counterclaim was “frivolous from the time it was filed.”

 

from Blogger http://tushnet.blogspot.com/2025/10/bad-lanham-act-claim-swept-up-with-bad.html

Posted in Uncategorized | Tagged , , | Leave a comment

allegedly false claims for compounded weight loss drugs didn’t plausibly threaten Eli Lilly’s reputation

Eli Lilly & Co. v. Mochi Health Corp., 2025 WL 2998166,
No. 25-cv-03534-JSC (N.D. Cal. Oct. 24, 2025)

Another of the cases in which Eli Lilly’s attempts to
protect its GLP-antagonist market do surprisingly badly, once again
highlighting the higher standards imposed on false advertising plaintiffs
compared to trademark plaintiffs. Lilly sued defendants, alleging a scheme to
mislead consumers into purchasing compounded versions of Lilly’s FDA-approved
medications, Mounjaro and Zepbound, under California state and federal false
advertising law. Defendants compound tirzepatide, which is the key ingredient
in Lilly’s drugs.

Mochi allegedly changed the dosages for all its customers
without consulting them or receiving a clinical indication from a physician, in
violation of California’s prohibition on the corporate practice of medicine. In
addition, Lilly alleged that Mochi also included “additives” such as
niacinamide and pyridoxine, without patient consent or a clinical indication. Lilly
points to a complaint posted by a Mochi customer on the Better Business
Bureau’s website, indicating their dissatisfaction with the unilateral decision
to add niacinamide to the compounded medication; the complaint said that the
customer had broken out in a rash, which a dermatologist opined was caused by
the niacinamide. Mochi released statements in response to customer queries,
claiming that the additives were “not clinically significant” and changes were
dependent on the pharmacy used to fill the prescription. Lilly alleged that
this again violated the prohibition on the corporate practice of medicine.

As for false advertising, Mochi allegedly misrepresented the
source of its products by claiming that it is a generic of Lilly’s Mounjaro and
Zepbound; misrepresented its compounded tirzepatide medications as safe and
effective based on studies conducted of Lilly’s products; falsely claimed that
its compounded tirzepatide drug was “personalized”; falsely claimed that its
pharmacy partner voluntarily stopped compounding tirzepatide medications; and
falsely advertising Mochi’s founder and CEO as a licensed physician.

How did this allegedly harm Lilly? Lilly alleged that it
suffered irreparable harm to its brand and goodwill because Mochi promised
unobtainable results and traded on the credibility of Lilly products. The
complaint alleged:

When consumers fail to achieve
desired results from Mochi Health’s combination injection, consumers may
conclude that tirzepatide is ineffective in general— an outcome made more
likely given Defendants’ reliance on Lilly’s clinical studies and their explicit
claims that their product functions identically to Lilly’s products, with the
additives having no clinical significance. Worse still, if consumers are harmed
using compounded tirzepatide products from Defendants—where their dosage and
formulation are subject to repeated arbitrary changes based solely on
Defendants’ business relationships without any clinical justification—consumers
may even draw unwarranted conclusions about the safety and effectiveness of
Lilly’s FDA-approved tirzepatide medicines.

The court found no Article III standing. The only harm Lilly
alleged to itself was reputational: if Mochi’s products didn’t work, consumers
might conclude that Lilly’s products were also ineffective, and if they harmed
consumers, consumers might conclude that Lilly’s products were also harmful.

Lilly argued that, given its claim of reputational injury,
competition wasn’t required for proximate cause; it was enough to allege that
the defendant damages the product’s reputation “by, for example, equating it
with an inferior product.” But that still required Lilly to allege a factual
basis to support its conclusion that its reputation has been damaged by
comparison to an inferior product. The complaint didn’t do so; it didn’t allege
that Mochi’s compounded product failed to help consumers lose weight, nor did
it allege facts that plausibly support an inference of failure. “Lilly appears
to argue the mere fact a medication is compounded makes it an inferior version
of an FDA-approved product with the same active pharmaceutical ingredient. But
compounding is a federally recognized and regulated pharmaceutical practice ….”
As a result [this is a proximate cause “as a result,” not a but-for cause “as a
result”], “the existence of compounded tirzepatide medications does not, in
itself, plausibly support harm to the reputation of a tirzepatide manufacturer.”
More would be required for this theory: “facts supporting an inference that
Mochi Health’s compounded medication fails to meet consumer expectations about
tirzepatide.”

Similarly, Lilly didn’t plausibly allege that Mochi customers
were harmed by the compounded medications “such that they could draw
unwarranted conclusions about the safety and efficacy” of Mounjaro or Zepbound.
A “lone internet post by an unidentified individual” didn’t support a plausible
inference that Mochi customers could reasonably draw a negative inference about
Lilly’s product. There were no allegations that Health misled consumers into
thinking there was no niacinamide, pyridoxine, or glycine in the medication; “the
customer who allegedly complained of a rash knew of the niacinamide in the
product prior to using it, and remarked on how it was a new addition compared
to their previous prescription.” Thus, this allegation showed a customer who
understood the difference, which wouldn’t support an inference that Lilly could
be harmed.   

No Article III standing, no federal case.  

from Blogger http://tushnet.blogspot.com/2025/10/allegedly-false-claims-for-compounded.html

Posted in Uncategorized | Tagged , , | Leave a comment

Coinbase can’t force claim for injunctive relief into arbitration

Khan v. Coinbase, Inc., 2025 WL 2985378, No. A172063, —
Cal.Rptr.3d —-, (Ct. App. Oct. 23, 2025)

The appellate court affirmed the denial of Coinbase’s
attempt to send Khan’s false advertising claims to arbitration, holding that
Khan sought public injunctive relief and that the arbitration agreement’s
attempted waiver of the right to seek public injunctive relief was invalid. It
rejected Coinbase’s argument that the relief sought was not for the “public”
because only people who signed up for a Coinbase account were exposed to the
targeted representations.

Coinbase is a digital currency exchange. Khan alleges that
Coinbase charges customers a “hidden” transaction fee, the spread fee. “For
example, when a customer seeks to make a purchase, the spread fee is not
displayed on any of the screens that the customer reviews when placing an
order. Nor is the spread fee included in the amount of the ‘Coinbase fee’ that
is displayed to consumers.” Instead, Coinbase quotes a market price for various
digital currencies, and after the customer indicates how much of a particular
currency he or she wants to purchase, the customer is shown an “Order Preview” with
a slightly higher price, either one or two percent. The only way for a customer
to discover that Coinbase is charging this added fee is if the customer clicks
a “tooltip” icon next to the word “Price.”

Coinbase allegedly designed its platform to take advantage
of less sophisticated customers by charging a spread fee only to consumers who
use Coinbase’s “default trading option,” and not imposing a spread fee on
customers who select the platform’s “Advanced” trading option. He brought UCL
and FAL claims
.

Coinbase’s TOS include an arbitration clause with a “Waiver
of Class and Other Non-Individualized Relief.” It states that “only individual
relief is available,” and it precludes any customer or user from consolidating
his or her dispute with that of another customer or user. Additional language
expressly prohibits an arbitrator from awarding non-individualized relief:
“Subject to this Arbitration Agreement, the arbitrator may award declaratory or
injunctive relief only in favor of the individual party seeking relief and only
to the extent necessary to provide relief warranted by the party’s individual
claim.” And a severability clause provides that if the waiver is deemed
“unenforceable as to a particular claim or request for relief (such as a
request for public injunctive relief),” that claim or request for relief shall
be severed and litigated in court. All disputes relating to the purported
waiver of class or other non-individualized relief “shall be decided by a court
of competent jurisdiction and not by an arbitrator.”

The trial court found that the arbitration agreement
contained an impermissible waiver of the right to obtain public injunctive
relief, and that Khan was indeed asserting claims for public injunctive relief.
“[T]he injunctive relief sought is not limited to private parties or the
putative class and will benefit the public at large,” and the “nature of the
harm alleged” and “the statutory basis” for Khan’s claims showed that he was
seeking public injunctive relief. Thus, he could not be required to arbitrate.

The California Supreme Court has held that a provision in
the parties’ arbitration agreement that purported to waive the right to seek
public injunctive relief in any forum was invalid. Injunctive relief available
under California’s consumer protection statutes can be either public or private:
“public injunctive relief … is relief that has ‘the primary purpose and
effect of’ prohibiting unlawful acts that threaten future injury to the general
public”; by contrast, relief “that has the primary purpose or effect of
redressing or preventing injury to an individual plaintiff—or to a group of
individuals similarly situated to the plaintiff—does not constitute public
injunctive relief.”

Public injunctive relief is available to private plaintiffs
suing for violations of California’s consumer protection statutes,
notwithstanding amendments to those laws that require private plaintiffs to
have suffered individual injury. A private plaintiff who has suffered an injury
in fact due to a violation of the UCL or FAL is filing the lawsuit “on his or
her own behalf, not ‘on behalf of the general public,’ ” even if one of the
remedies sought is injunctive relief, “ ‘the primary purpose and effect of’
which is ‘to prohibit and enjoin conduct that is injurious to the general
public.’ ”

The waiver of public injunctive relief was invalid under
Cal. Civil Code section 3153, which provides: “Any one may waive the advantage
of a law intended solely for their benefit. But a law established for a public
reason cannot be contravened by a private agreement.” Waiver of a statutory
right is permissible only if the “ ‘statute’s “public benefit … is merely
incidental to [its] primary purpose,” ’ ” and “ ‘ “any public purpose” ’ ”
would not be seriously compromised by the waiver. This is not true of waiver of
public injunctive relief under consumer protection laws.

Here, “Khan alleges that particular Coinbase conduct in
operating its online cryptocurrency exchange constitutes a deceptive business
practice that is likely to deceive or confuse the public; he alleges this
unlawful conduct is ongoing; and he seeks injunctive relief solely to prohibit
Coinbase from continuing to violate the statutes in this manner.” That was
enough to establish the public nature of the relief Khan sought, and how that
relief would benefit the general public if he is able to establish his claim. “[A]
complaint to enjoin future violations of California’s consumer protection laws
seeks public injunctive relief when the relief sought is not limited to the
plaintiff or a defined group, but is oriented to and for the benefit of the
public at large.”  Here, Khan sought
relief against practices that allegedly mislead members of the public who seek
to buy, sell, or convert digital currency on Coinbase’s platform.

Thus, the waiver was invalid, even if included in an
arbitration agreement; arbitration is on an equal footing with other contracts,
but the FAA’s savings clause permits courts to declare arbitration agreements
unenforceable “ ‘ “upon such grounds as exist at law or in equity for the
revocation of any contract.” ’ ” “The principle that a law established for a
public purpose cannot be contravened by private agreement is a generally
applicable contract defense, not a defense that applies only to arbitration or
that derives its meaning from the fact an arbitration agreement is at issue.”

 

Coinbase contended that the relief sought in the complaint was
private because Khan sought to compel Coinbase to make additional disclosures
to existing customers, and thus challenged conduct that is not directed at the
public. But the complaint didn’t seek an order compelling Coinbase to make any
disclosures specifically to Khan or any defined group of individuals.

Coinbase responded that the injunction Khan seeks couldn’t
possibly benefit the public because only existing Coinbase customers could
access the platform on which the allegedly unlawful conduct occurs. But the
court wasn’t willing to allow Coinbase to “insulate itself from a public
injunction simply by requiring a consumer to create a user account before
engaging with Coinbase and its platform. In our view, the unlawful business
practice that Khan describes and seeks to enjoin affects the general public
because any member of the public may access and elect to use Coinbase’s online
platform.” The user account requirement was “simply the online equivalent of
driving to, parking at, and walking into a brick-and-mortar store,” “the
threshold a potential customer must cross before transacting business with
Coinbase.” Coinbase did not “demonstrate that it restricts access to its
services in a meaningful way,” or that “any member of the public cannot simply
create credentials and access Coinbase’s services.” “[W]e would surely say that
an injunction preventing a grocery store from advertising one price in the
grocery aisle, while charging a higher price at the register, was a public
injunction even though it protected only customers who entered the store to buy
groceries.”

Coinbase argued that the threshold of establishing a user
account was materially different from walking into a store because signing up
for a user account requires a potential customer to sign a contract agreeing to
arbitrate claims, “but of course no agreement to arbitrate a claim seeking
public injunctive relief is enforceable, so we do not see this difference as
dispositive.”

In addition, conduct directed at a defendant’s customers can
at least sometimes support a request for public injunctive relief. “When the
primary purpose of an injunction is to prohibit an ongoing violation of
consumer protection laws, the relief sought is usually public relief because
the benefit to the plaintiff or a group of similarly situated individuals is
not materially different from the benefit that inures to the broader public.” Here,
Khan wasn’t seeking a specific change to Coinbase’s platform that would benefit
him alone, or existing account holders alone, but not members of the public who
become future users of the Coinbase platform. An injunction can both benefit a business’s
existing customers and also benefit the public generally.

from Blogger http://tushnet.blogspot.com/2025/10/coinbase-cant-force-claim-for.html

Posted in Uncategorized | Tagged , | Leave a comment